Patients Anxiety and Depression
9:00 am to 1:00 pm – 9 August 2018
NEW INSIGHTS & TREATMENT
EARN CPE AND CPD POINTS
The Anxiety and Depression 1/2 Day Summit
Antidepressants don’t work for many patients and Dr Kelly Brogan in the US would go so far as to say they are not the answer. So what can we do to improve anxiety and depression?
Come to Sydney to listen to the world specialists in methylation.
Dr Ben Lynch will be presenting via live satellite from the US. Which COMT are you?
Carolyn Ledowsky will be speaking about the importance of key nutrients to improve anxiety and depression scores.
Dr Detlev Boison is traveling from Portland Oregon, USA and will be discussing the ketogenic diet and how it may have a direct affect on mood.
Dont miss this unique event. It will not be recorded and places are limited so make sure you book now.
I hope you will join us
Carolyn ledowsky has become the leader in the field of MTHFR and methylation in Australia. She founded MTHFR Support Australia with a goal to raising the awareness of how MTHFR genetic polymorphisms may affect health. This has lead to the existence of the largest MTHFR and methylation clinic in the world. Carolyn and her team of practitioners work with patients from all over the world. MTHFR Support Australia this year, launched its own brand of products dedicated to patients with MTHFR and methylation issues. … Read More
Dr. Ben Lynch received his Cell and Molecular Biology, BS from the University of Washington and his ND from Bastyr University. His passion for identifying the cause of disease directed him towards nutrigenomics and methylation dysfunction. Currently, he researches, writes and presents worldwide on the topic of MTHFR and methylation defects. He is the author of Dirty Genes. You may learn
more about Dr. Lynch and his work at www.drbenlynch.com.
Having a passion for translational research and for finding cures for intractable conditions that cause human suffrage and death, I seek to translate fundamental mechanisms of biochemistry and energy homeostasis into novel therapeutic approaches for the treatment of neurological and psychiatric conditions and cancer. A major research effort is the development of therapies that restore the equilibrium of adenosine and associated epigenetic changes and thereby reset the ‘disease clock’.
The Concourse, 409 Victoria Avenue, Chatswood, Sydney